Urokinase-type plasminogen activator receptor

The use of substances capable of preventing the binding of a receptor binding form of u-PA to a u-PA receptor (u-PAR) in a mammal and thereby preventing u-PA from converting plasminogen into plasmin thereby preventing cell surface plasminogen activation which is believed to play an important role in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MOELLER, LISBETH BIRK, APPELLA, ETTORE, SALONEN, EEVA-MARJATTE, POELLAENEN, JARI, LUND, LEIF ROEGE, PLOUG, MICHAEL, VAHERI, ANTTI, ELLIS, VINCENT, CUBELLIS, MARIA VITTORIA, ROLDAN, ANN LOURING, BLASI, FRANCESCO, TAPIOVAARA, HANNELE, SCHLEUNING, WOLF DIETER, STEPHENS, ROSS W, BEHRENDT, NIELS, PYKE, CHARLES, ROENNE, EBBE, KRISTESEN, PETER, DANO, KELD, MASUCCI, MARIA TERESA
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The use of substances capable of preventing the binding of a receptor binding form of u-PA to a u-PA receptor (u-PAR) in a mammal and thereby preventing u-PA from converting plasminogen into plasmin thereby preventing cell surface plasminogen activation which is believed to play an important role in tissue remodelling, particularly during cancer invasion for preparing a composition for preventing or counteracting localized proteolytic activity in a mammal, in particular a human.